Abstract
Summary
Europe Anti-Acne Dermal Patch Market Research Report Forecast to 2030
Market Overview
The growth of the Europe anti-acne dermal patch market is attributed to the rising prevalence of acne vulgaris across Europe, increasing sedentary lifestyles and unhealthy food habits, and the high influence of social media and brand endorsements. However, the concerns pertaining to rashes and allergies might hamper the market's growth in the forecast period. Nevertheless, it is anticipated that the growing adoption of chemical-free products among consumers will create lucrative opportunities for the players operating in the European anti-acne dermal patch market.
The Europe anti-acne dermal patch market is emerging due to the rising prevalence of acne vulgaris across Europe, increasing sedentary lifestyles and unhealthy food habits, and the high influence of social media and brand endorsements. Additionally, the growing adoption of chemical-free products among consumers will provide growth opportunities for the market in the future. However, the concerns pertaining to rashes and allergies might hamper the market's growth in the forecast period.
Market Segmentation
Based on acne type, the Europe anti-acne dermal patch market has been segmented into inflammatory and non-inflammatory acne.
Based on patch type, the Europe anti-acne dermal patch market has been segmented into medicated, non-medicated, and micro-needle. Medicated further segmented into hydrocolloid based, salicylic acid-based, and hyaluronic acid-based.
Based on ingredient type, the Europe anti-acne dermal patch market has been segmented into chemical based and herbal-based. Based on the distribution channel, the Europe anti-acne dermal patch market has been segmented into retail stores, pharmacies & drug stores, and e-commerce platforms.
The Europe region is comprised of countries including Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Europe region is driven by several factors, including high consumption of cigarette smoke among men, an increasing prevalence of acne vulgaris among women, and an increasing prevalence of comorbid diseases such as polycystic ovary syndrome, diabetes, and obesity among women. Germany country dominated the market in 2021 and France is projected to be the fastest-growing during the forecast period, 2022–2030.
Major Players
3M (US), Church & Dwight Co Inc (US), EcoFeminii Ltd (US), Avalon Natural Products, Inc (US), ZitSticka (US), Mario Badescu Skin Care Inc (US), Starface (US), Peace Out LLC (US), COSRX (South Korea), and Peach & Lilly (US) are key players in the market.
Table of Contents
1 EXECUTIVE SUMMARY 12
1.1 OVERVIEW 12
2 MARKET INTRODUCTION 13
2.1 DEFINITION 13
2.2 SCOPE OF THE STUDY 13
2.3 RESEARCH OBJECTIVE 13
2.4 MARKET STRUCTURE 14
2.5 ASSUMPTIONS & LIMITATIONS 15
3 RESEARCH METHODOLOGY 16
3.1 DATA MINING 16
3.2 SECONDARY RESEARCH 17
3.3 PRIMARY RESEARCH 18
3.4 BREAKDOWN OF PRIMARY RESPONDENTS 19
3.5 FORECASTING TECHNIQUES 20
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION 21
3.6.1 BOTTOM-UP APPROACH 22
3.6.2 TOP-DOWN APPROACH 22
3.7 DATA TRIANGULATION 22
3.8 VALIDATION 23
4 MARKET DYNAMICS 24
4.1 OVERVIEW 24
4.2 DRIVERS 25
4.2.1 RISING PREVALENCE OF ACNE VULGARIS ACROSS EUROPE 25
4.2.2 INCREASING SEDENTARY LIFESTYLE AND UNHEALTHY FOOD HABITS 25
4.2.3 HIGH INFLUENCE OF SOCIAL MEDIA AND BRAND ENDORSEMENTS 25
4.3 RESTRAINTS 26
4.3.1 CONCERNS PERTAINING TO RASHES AND ALLERGIES 26
4.4 OPPORTUNITY 27
4.4.1 GROWING ADOPTION OF CHEMICAL-FREE PRODUCTS AMONG CONSUMERS 27
5 MARKET FACTOR ANALYSIS 28
5.1 VALUE CHAIN ANALYSIS 28
5.1.1 R&D 29
5.1.2 MANUFACTURING 29
5.1.3 MARKETING AND DISTRIBUTION 29
5.1.4 POST-SALES MONITORING 29
5.2 PORTER'S FIVE FORCES MODEL 30
5.2.1 THREAT OF NEW ENTRANTS 30
5.2.2 BARGAINING POWER OF SUPPLIERS 31
5.2.3 THREAT OF SUBSTITUTES 31
5.2.4 BARGAINING POWER OF BUYERS 31
5.2.5 INTENSITY OF RIVALRY 31
5.3 IMPACT OF COVID-19 ON THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 32
6 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY ACNE TYPE 33
6.1 OVERVIEW 33
6.2 INFLAMMATORY ACNE 34
6.3 NON-INFLAMMATORY ACNE 35
7 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY PATCH TYPE 36
7.1 OVERVIEW 36
7.2 MEDICATED 37
7.3 NON-MEDICATED 38
7.4 MICRO-NEEDLE 38
8 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY INGREDIENT TYPE 39
8.1 OVERVIEW 39
8.2 CHEMICAL BASED 40
8.2.1 HYDROCOLLOID BASED 41
8.2.2 SALICYLIC ACID BASED 42
8.2.3 HYALURONIC ACID BASED 42
8.3 HERBAL BASED 43
9 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY DISTRIBUTION CHANNEL 44
9.1 OVERVIEW 44
9.2 RETAIL STORES 46
9.3 PHARMACIES & DRUG STORES 46
9.4 E-COMMERCE PLATFORM 47
10 EUROPE ANTI-ACNE DERMAL PATCH MARKET, BY COUNTRY 48
10.1 OVERVIEW 48
10.1.1 GERMANY 52
10.1.2 FRANCE 54
10.1.3 UK 56
10.1.4 ITALY 58
10.1.5 SPAIN 60
10.1.6 REST OF EUROPE 63
11 COMPETITIVE LANDSCAPE 65
11.1 OVERVIEW 65
11.2 COMPETITIVE BENCHMARKING 66
11.3 MAJOR GROWTH STRATEGY IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 67
11.4 THE LEADING PLAYER IN TERMS OF THE NUMBER OF DEVELOPMENTS IN THE EUROPE ANTI-ACNE DERMAL PATCH MARKET 68
11.5 KEY DEVELOPMENT ANALYSIS 68
11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES 69
11.6.1 PRODUCT APPROVAL AND PRODUCT LAUNCHES 69
11.6.2 ACQUISITION 69
11.7 FINANCIAL MATRIX 69
11.7.1 SALES (USD MILLION), 2021 69
11.7.2 RESEARCH & DEVELOPMENT EXPENDITURE (USD MILLION), 2021 70
12 COMPANY PROFILES 71
12.1 3M 71
12.1.1 COMPANY OVERVIEW 71
12.1.2 FINANCIAL OVERVIEW 72
12.1.3 PRODUCTS OFFERED 72
12.1.4 KEY DEVELOPMENTS 73
12.1.5 SWOT ANALYSIS 73
12.1.6 KEY STRATEGIES 73
12.2 ECOFEMINII LTD 74
12.2.1 COMPANY OVERVIEW 74
12.2.2 FINANCIAL OVERVIEW 74
12.2.3 PRODUCTS OFFERED 74
12.2.4 KEY DEVELOPMENTS 74
12.2.5 KEY STRATEGIES 74
12.3 AVALON NATURAL PRODUCTS, INC 75
12.3.1 COMPANY OVERVIEWS 75
12.3.2 FINANCIAL OVERVIEW 75
12.3.3 PRODUCTS OFFERED 75
12.3.4 KEY DEVELOPMENTS 75
12.3.5 SWOT ANALYSIS 76
12.3.6 KEY STRATEGIES 76
12.4 ZITSTICKA 77
12.4.1 COMPANY OVERVIEW 77
12.4.2 FINANCIAL OVERVIEW 77
12.4.3 PRODUCTS OFFERED 77
12.4.4 KEY DEVELOPMENTS 77
12.4.5 KEY STRATEGIES 78
12.5 MARIO BADESCU SKIN CARE, INC 79
12.5.1 COMPANY OVERVIEW 79
12.5.2 FINANCIAL OVERVIEW 79
12.5.3 PRODUCTS OFFERED 79
12.5.4 KEY DEVELOPMENTS 79
12.5.5 KEY STRATEGIES 79
12.6 CHURCH & DWIGHT CO., INC 80
12.6.1 COMPANY OVERVIEWS 80
12.6.2 FINANCIAL OVERVIEW 80
12.6.3 PRODUCTS OFFERED 81
12.6.4 KEY DEVELOPMENTS 81
12.6.5 SWOT ANALYSIS 81
12.6.6 KEY STRATEGIES 82
12.7 STARFACE 83
12.7.1 COMPANY OVERVIEW 83
12.7.2 FINANCIAL OVERVIEW 83
12.7.3 PRODUCTS OFFERED 83
12.7.4 STARFACE: KEY DEVELOPMENTS 83
12.7.5 SWOT ANALYSIS 84
12.7.6 KEY STRATEGIES 84
12.8 PEACE OUT, LLC 85
12.8.1 COMPANY OVERVIEW 85
12.8.2 FINANCIAL OVERVIEW 85
12.8.3 PRODUCTS OFFERED 85
12.8.4 KEY DEVELOPMENTS 85
12.8.5 SWOT ANALYSIS 86
12.8.6 KEY STRATEGIES 86
12.9 COSRX 87
12.9.1 COMPANY OVERVIEW 87
12.9.2 FINANCIAL OVERVIEW 87
12.9.3 PRODUCTS OFFERED 87
12.9.4 KEY DEVELOPMENTS 87
12.9.5 KEY STRATEGIES 87
12.10 PEACH & LILLY 88
12.10.1 COMPANY OVERVIEW 88
12.10.2 FINANCIAL OVERVIEW 88
12.10.3 PRODUCTS OFFERED 88
12.10.4 KEY DEVELOPMENTS 88
12.10.5 KEY STRATEGIES 88
13 APPENDIX 89
13.1 REFERENCES 89
13.1.1 EUROPEAN SOCIETY FOR DERMATOLOGY AND PSYCHIATRY 89
13.1.2 EUROPEAN DERMATOLOGY FORUM 89
13.1.3 THE EUROPEAN SOCIETY FOR DERMATOLOGICAL RESEARCH (ESDR) 89
13.1.4 EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY 89
13.1.5 EUROPEAN SOCIETY FOR COSMETIC AND AESTHETIC DERMATOLOGY 89
13.1.6 BRITISH ASSOCIATION OF DERMATOLOGISTS 89
13.1.7 FRENCH SOCIETY OF DERMATOLOGY 89
13.1.8 THE ITALIAN SOCIETY OF DERMATOLOGY 89
13.1.9 SPANISH ASSOCIATION OF DERMATOLOGY AND VENEREOLOGY 89
13.1.10 BRITISH ASSOCIATION OF DERMATOLOGISTS 89
13.2 RELATED REPORTS 89